

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of memory T cell differentiation (GO:0043380) | 7.50082032 |
| 2 | regulation of MHC class I biosynthetic process (GO:0045343) | 6.60618902 |
| 3 | negative regulation of multicellular organism growth (GO:0040015) | 6.01033255 |
| 4 | cellular ketone body metabolic process (GO:0046950) | 5.56112276 |
| 5 | regulation of establishment of cell polarity (GO:2000114) | 5.41846206 |
| 6 | regulation of interleukin-13 production (GO:0032656) | 5.39853429 |
| 7 | cytoplasmic mRNA processing body assembly (GO:0033962) | 5.30656282 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 4.90188640 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 4.90188640 |
| 10 | tryptophan catabolic process (GO:0006569) | 4.90188640 |
| 11 | ketone body metabolic process (GO:1902224) | 4.84854437 |
| 12 | negative regulation of type 2 immune response (GO:0002829) | 4.63289864 |
| 13 | kynurenine metabolic process (GO:0070189) | 4.59647544 |
| 14 | cellular response to type I interferon (GO:0071357) | 4.59072310 |
| 15 | type I interferon signaling pathway (GO:0060337) | 4.59072310 |
| 16 | response to type I interferon (GO:0034340) | 4.57211082 |
| 17 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 4.20113158 |
| 18 | tryptophan metabolic process (GO:0006568) | 3.97914046 |
| 19 | nucleoside diphosphate catabolic process (GO:0009134) | 3.94957357 |
| 20 | sex differentiation (GO:0007548) | 3.93320830 |
| 21 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.90283772 |
| 22 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.88118727 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.87795324 |
| 24 | negative regulation of mast cell activation (GO:0033004) | 3.67642423 |
| 25 | NAD biosynthetic process (GO:0009435) | 3.67392983 |
| 26 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.63215390 |
| 27 | ADP metabolic process (GO:0046031) | 3.58595618 |
| 28 | regulation of action potential (GO:0098900) | 3.54663584 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.53974804 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.51477023 |
| 31 | sterol catabolic process (GO:0016127) | 3.45446183 |
| 32 | cholesterol catabolic process (GO:0006707) | 3.45446183 |
| 33 | positive regulation of heat generation (GO:0031652) | 3.41338488 |
| 34 | B cell homeostasis (GO:0001782) | 3.40341437 |
| 35 | indolalkylamine metabolic process (GO:0006586) | 3.38490247 |
| 36 | DNA demethylation (GO:0080111) | 3.38174773 |
| 37 | cytidine deamination (GO:0009972) | 3.37335582 |
| 38 | cytidine metabolic process (GO:0046087) | 3.37335582 |
| 39 | cytidine catabolic process (GO:0006216) | 3.37335582 |
| 40 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.26284542 |
| 41 | snRNA transcription (GO:0009301) | 3.23052290 |
| 42 | positive regulation of vasculogenesis (GO:2001214) | 3.18407369 |
| 43 | L-fucose catabolic process (GO:0042355) | 3.15496777 |
| 44 | fucose catabolic process (GO:0019317) | 3.15496777 |
| 45 | L-fucose metabolic process (GO:0042354) | 3.15496777 |
| 46 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.14900232 |
| 47 | neural tube formation (GO:0001841) | 3.11083953 |
| 48 | interferon-gamma production (GO:0032609) | 3.10438948 |
| 49 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.09849026 |
| 50 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.09849026 |
| 51 | endoderm formation (GO:0001706) | 3.09225794 |
| 52 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.07648193 |
| 53 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.03826205 |
| 54 | regulation of metalloenzyme activity (GO:0048552) | 2.99850149 |
| 55 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.99549500 |
| 56 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.99420848 |
| 57 | defense response to protozoan (GO:0042832) | 2.97793542 |
| 58 | negative regulation of macroautophagy (GO:0016242) | 2.96702506 |
| 59 | amine catabolic process (GO:0009310) | 2.96694269 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 2.96694269 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.96576665 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 2.95237855 |
| 63 | T cell costimulation (GO:0031295) | 2.90290414 |
| 64 | negative regulation of T cell differentiation (GO:0045581) | 2.90058363 |
| 65 | B cell proliferation (GO:0042100) | 2.86866818 |
| 66 | aromatic amino acid family catabolic process (GO:0009074) | 2.86498703 |
| 67 | lymphocyte costimulation (GO:0031294) | 2.85794522 |
| 68 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.84592591 |
| 69 | positive regulation of defense response to virus by host (GO:0002230) | 2.83346404 |
| 70 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.81803634 |
| 71 | DNA dealkylation (GO:0035510) | 2.81767503 |
| 72 | regulation of interleukin-5 production (GO:0032674) | 2.78716725 |
| 73 | photoreceptor cell maintenance (GO:0045494) | 2.75944362 |
| 74 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.74587221 |
| 75 | response to interferon-gamma (GO:0034341) | 2.74479933 |
| 76 | regulation of sarcomere organization (GO:0060297) | 2.73113331 |
| 77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.72819089 |
| 78 | cellular response to interferon-gamma (GO:0071346) | 2.71658125 |
| 79 | positive regulation of antigen processing and presentation (GO:0002579) | 2.69624743 |
| 80 | synaptic transmission, cholinergic (GO:0007271) | 2.69080628 |
| 81 | regulation of heat generation (GO:0031650) | 2.68680774 |
| 82 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.68445760 |
| 83 | regulation of germinal center formation (GO:0002634) | 2.67933167 |
| 84 | regulation of antigen processing and presentation (GO:0002577) | 2.67681253 |
| 85 | response to protozoan (GO:0001562) | 2.67287969 |
| 86 | establishment of protein localization to Golgi (GO:0072600) | 2.66805816 |
| 87 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.66208451 |
| 88 | regulation of type 2 immune response (GO:0002828) | 2.65953426 |
| 89 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.65612539 |
| 90 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.65612539 |
| 91 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.64885217 |
| 92 | stress granule assembly (GO:0034063) | 2.64123651 |
| 93 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 2.61420256 |
| 94 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.61420256 |
| 95 | histone H3-K4 trimethylation (GO:0080182) | 2.60724684 |
| 96 | protein-chromophore linkage (GO:0018298) | 2.60056557 |
| 97 | proline transport (GO:0015824) | 2.59085014 |
| 98 | T-helper 1 type immune response (GO:0042088) | 2.57074679 |
| 99 | protein autoprocessing (GO:0016540) | 2.55751909 |
| 100 | B cell mediated immunity (GO:0019724) | 2.54845973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.79739838 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.26585766 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.36505882 |
| 4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.88569397 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.82889844 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.82218733 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.66995532 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.58122106 |
| 9 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.33818516 |
| 10 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05970178 |
| 11 | BCAT_22108803_ChIP-Seq_LS180_Human | 2.03007322 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.96524865 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.89970381 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.81863992 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.81359571 |
| 16 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.77369403 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70854759 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.67334430 |
| 19 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.67101823 |
| 20 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.67000083 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 1.66271864 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.56471776 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56099766 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.50151558 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.49576277 |
| 26 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.49507213 |
| 27 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.47940723 |
| 28 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.47940723 |
| 29 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.47719518 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.45176636 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.45000860 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.43674825 |
| 33 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.43568462 |
| 34 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.42424084 |
| 35 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41840846 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41792867 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.40706891 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37815608 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.36362228 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.29914679 |
| 41 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.29720427 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28768852 |
| 43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26360937 |
| 44 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26349701 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25490615 |
| 46 | NCOR_22424771_ChIP-Seq_293T_Human | 1.25154232 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.24876688 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24606963 |
| 49 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23957286 |
| 50 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22148640 |
| 51 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.21814972 |
| 52 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20687043 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20266529 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19635616 |
| 55 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18485154 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18485154 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17596145 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16029160 |
| 59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15957199 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15650327 |
| 61 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15220595 |
| 62 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.14790433 |
| 63 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14785252 |
| 64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.14612463 |
| 65 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.12686058 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11922544 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11602670 |
| 68 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10010571 |
| 69 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.09610427 |
| 70 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07713462 |
| 71 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07457650 |
| 72 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.07319065 |
| 73 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.07128024 |
| 74 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06837476 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06707414 |
| 76 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06368771 |
| 77 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06338355 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06021800 |
| 79 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.05338929 |
| 80 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.04052255 |
| 81 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02985213 |
| 82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01655930 |
| 83 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01582883 |
| 84 | P300_27268052_Chip-Seq_Bcells_Human | 1.01487673 |
| 85 | MYB_26560356_Chip-Seq_TH1_Human | 1.01232271 |
| 86 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00479583 |
| 87 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00186559 |
| 88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99527645 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98862628 |
| 90 | GATA3_26560356_Chip-Seq_TH1_Human | 0.98711424 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98473043 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98178438 |
| 93 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.98095661 |
| 94 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97652164 |
| 95 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97615110 |
| 96 | ERA_21632823_ChIP-Seq_H3396_Human | 0.97119869 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95993902 |
| 98 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95249199 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95006875 |
| 100 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94698720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 3.94970992 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 3.83342938 |
| 3 | MP0003252_abnormal_bile_duct | 3.71239142 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.69022299 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.97529349 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 2.86074661 |
| 7 | MP0005379_endocrine/exocrine_gland_phen | 2.60879006 |
| 8 | MP0005387_immune_system_phenotype | 2.57702159 |
| 9 | MP0001790_abnormal_immune_system | 2.57702159 |
| 10 | MP0005671_abnormal_response_to | 2.56236207 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.46418990 |
| 12 | MP0003011_delayed_dark_adaptation | 2.30848949 |
| 13 | MP0001986_abnormal_taste_sensitivity | 2.30131523 |
| 14 | MP0001800_abnormal_humoral_immune | 2.27841039 |
| 15 | MP0006072_abnormal_retinal_apoptosis | 2.20679182 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.13770071 |
| 17 | MP0001348_abnormal_lacrimal_gland | 1.98717107 |
| 18 | MP0002163_abnormal_gland_morphology | 1.96709354 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 1.95987684 |
| 20 | MP0005310_abnormal_salivary_gland | 1.94707680 |
| 21 | MP0000371_diluted_coat_color | 1.80576150 |
| 22 | MP0005253_abnormal_eye_physiology | 1.78074472 |
| 23 | MP0001873_stomach_inflammation | 1.75175658 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.72213139 |
| 25 | MP0002693_abnormal_pancreas_physiology | 1.70047531 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.68031074 |
| 27 | MP0002006_tumorigenesis | 1.63412297 |
| 28 | MP0005410_abnormal_fertilization | 1.63022896 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.58865035 |
| 30 | MP0009046_muscle_twitch | 1.57350151 |
| 31 | MP0005075_abnormal_melanosome_morpholog | 1.55853084 |
| 32 | MP0002723_abnormal_immune_serum | 1.55479228 |
| 33 | MP0003868_abnormal_feces_composition | 1.53095370 |
| 34 | MP0001944_abnormal_pancreas_morphology | 1.51441868 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.50854312 |
| 36 | MP0003195_calcinosis | 1.47297531 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.43330148 |
| 38 | MP0002254_reproductive_system_inflammat | 1.36065031 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.35078656 |
| 40 | MP0002420_abnormal_adaptive_immunity | 1.34363349 |
| 41 | MP0001819_abnormal_immune_cell | 1.30992586 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.30882661 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.29069918 |
| 44 | MP0009780_abnormal_chondrocyte_physiolo | 1.28794459 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.27921189 |
| 46 | MP0009745_abnormal_behavioral_response | 1.25595137 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.24732010 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.24641619 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.24556963 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.23212704 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.20123353 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.14197189 |
| 53 | MP0009785_altered_susceptibility_to | 1.11342898 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.10520763 |
| 55 | MP0002735_abnormal_chemical_nociception | 1.10491826 |
| 56 | MP0003303_peritoneal_inflammation | 1.06354877 |
| 57 | MP0005670_abnormal_white_adipose | 1.03865768 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.02975046 |
| 59 | MP0010386_abnormal_urinary_bladder | 1.02802554 |
| 60 | MP0005025_abnormal_response_to | 1.02387192 |
| 61 | MP0005360_urolithiasis | 1.02004855 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.01800333 |
| 63 | MP0002736_abnormal_nociception_after | 0.98863027 |
| 64 | MP0003950_abnormal_plasma_membrane | 0.96867114 |
| 65 | MP0000716_abnormal_immune_system | 0.95662309 |
| 66 | MP0002822_catalepsy | 0.95639954 |
| 67 | MP0003045_fibrosis | 0.95589192 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 0.94707672 |
| 69 | MP0005448_abnormal_energy_balance | 0.93568124 |
| 70 | MP0002909_abnormal_adrenal_gland | 0.93103979 |
| 71 | MP0005332_abnormal_amino_acid | 0.90940587 |
| 72 | MP0002928_abnormal_bile_duct | 0.90549172 |
| 73 | MP0000427_abnormal_hair_cycle | 0.90123129 |
| 74 | MP0001764_abnormal_homeostasis | 0.90064135 |
| 75 | MP0009840_abnormal_foam_cell | 0.89043864 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.88427641 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 0.88261672 |
| 78 | MP0008872_abnormal_physiological_respon | 0.88051147 |
| 79 | MP0002398_abnormal_bone_marrow | 0.84114189 |
| 80 | MP0010155_abnormal_intestine_physiology | 0.83759640 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 0.83585838 |
| 82 | MP0001666_abnormal_nutrient_absorption | 0.81266877 |
| 83 | MP0004264_abnormal_extraembryonic_tissu | 0.81162591 |
| 84 | MP0000516_abnormal_urinary_system | 0.77324711 |
| 85 | MP0005367_renal/urinary_system_phenotyp | 0.77324711 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.76720668 |
| 87 | MP0003879_abnormal_hair_cell | 0.72947545 |
| 88 | MP0002722_abnormal_immune_system | 0.72751338 |
| 89 | MP0003137_abnormal_impulse_conducting | 0.72397844 |
| 90 | MP0002638_abnormal_pupillary_reflex | 0.72145317 |
| 91 | MP0003718_maternal_effect | 0.71476890 |
| 92 | MP0004270_analgesia | 0.71233846 |
| 93 | MP0000538_abnormal_urinary_bladder | 0.70504884 |
| 94 | MP0002429_abnormal_blood_cell | 0.69559648 |
| 95 | MP0002419_abnormal_innate_immunity | 0.67924905 |
| 96 | MP0005647_abnormal_sex_gland | 0.67251006 |
| 97 | MP0000609_abnormal_liver_physiology | 0.66703448 |
| 98 | MP0004924_abnormal_behavior | 0.66470972 |
| 99 | MP0005386_behavior/neurological_phenoty | 0.66470972 |
| 100 | MP0005636_abnormal_mineral_homeostasis | 0.66456289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dysmetric saccades (HP:0000641) | 5.69640175 |
| 2 | Genetic anticipation (HP:0003743) | 5.40683628 |
| 3 | Progressive cerebellar ataxia (HP:0002073) | 5.32573114 |
| 4 | Prostate neoplasm (HP:0100787) | 4.84262148 |
| 5 | Severe visual impairment (HP:0001141) | 4.80483269 |
| 6 | Gastrointestinal stroma tumor (HP:0100723) | 4.64641663 |
| 7 | Gaze-evoked nystagmus (HP:0000640) | 4.17460350 |
| 8 | Pendular nystagmus (HP:0012043) | 4.17457239 |
| 9 | Action tremor (HP:0002345) | 4.16108897 |
| 10 | Agammaglobulinemia (HP:0004432) | 3.84671577 |
| 11 | Postural tremor (HP:0002174) | 3.41856578 |
| 12 | Recurrent sinusitis (HP:0011108) | 3.37987923 |
| 13 | IgA deficiency (HP:0002720) | 3.31070242 |
| 14 | Abnormality of the prostate (HP:0008775) | 3.30746788 |
| 15 | Chronic diarrhea (HP:0002028) | 3.23812983 |
| 16 | Pigmentary retinal degeneration (HP:0001146) | 3.02219022 |
| 17 | Increased density of long bones (HP:0006392) | 3.01746014 |
| 18 | Lymphopenia (HP:0001888) | 3.01562112 |
| 19 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.91766466 |
| 20 | Hyperventilation (HP:0002883) | 2.81591661 |
| 21 | Recurrent bronchitis (HP:0002837) | 2.80361415 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 2.71090384 |
| 23 | Abnormality of macular pigmentation (HP:0008002) | 2.68635974 |
| 24 | Proximal tubulopathy (HP:0000114) | 2.61909209 |
| 25 | Limb ataxia (HP:0002070) | 2.59633726 |
| 26 | Abnormality of the hepatic vasculature (HP:0006707) | 2.57848474 |
| 27 | Congenital stationary night blindness (HP:0007642) | 2.56530527 |
| 28 | Emphysema (HP:0002097) | 2.53128161 |
| 29 | Double outlet right ventricle (HP:0001719) | 2.50293922 |
| 30 | Congenital malformation of the right heart (HP:0011723) | 2.50293922 |
| 31 | Dialeptic seizures (HP:0011146) | 2.48184106 |
| 32 | Absence seizures (HP:0002121) | 2.44040280 |
| 33 | Impaired vibratory sensation (HP:0002495) | 2.42318742 |
| 34 | Congenital sensorineural hearing impairment (HP:0008527) | 2.40629018 |
| 35 | IgG deficiency (HP:0004315) | 2.39932016 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.39711624 |
| 37 | Vasculitis (HP:0002633) | 2.33628017 |
| 38 | Meningitis (HP:0001287) | 2.32416255 |
| 39 | Chronic otitis media (HP:0000389) | 2.31407041 |
| 40 | Hypoplasia of the uterus (HP:0000013) | 2.29371130 |
| 41 | Unilateral renal agenesis (HP:0000122) | 2.29361034 |
| 42 | Impaired smooth pursuit (HP:0007772) | 2.29306522 |
| 43 | IgM deficiency (HP:0002850) | 2.25335423 |
| 44 | Attenuation of retinal blood vessels (HP:0007843) | 2.22270501 |
| 45 | Type 2 muscle fiber atrophy (HP:0003554) | 2.21487463 |
| 46 | Abnormality of male internal genitalia (HP:0000022) | 2.18814267 |
| 47 | Abnormality of vitamin B metabolism (HP:0004340) | 2.18713263 |
| 48 | Postural instability (HP:0002172) | 2.17327648 |
| 49 | Bronchiectasis (HP:0002110) | 2.12878818 |
| 50 | Restrictive lung disease (HP:0002091) | 2.11042156 |
| 51 | Intestinal atresia (HP:0011100) | 2.07721835 |
| 52 | Slow saccadic eye movements (HP:0000514) | 2.04850898 |
| 53 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.03589115 |
| 54 | Abnormality of urine glucose concentration (HP:0011016) | 2.01051929 |
| 55 | Glycosuria (HP:0003076) | 2.01051929 |
| 56 | Popliteal pterygium (HP:0009756) | 1.99015823 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 1.97482939 |
| 58 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.97482939 |
| 59 | Late onset (HP:0003584) | 1.96991431 |
| 60 | Recurrent pneumonia (HP:0006532) | 1.95426285 |
| 61 | Inflammation of the large intestine (HP:0002037) | 1.92299092 |
| 62 | Chronic sinusitis (HP:0011109) | 1.90366533 |
| 63 | Abnormal albumin level (HP:0012116) | 1.88772343 |
| 64 | Hypoalbuminemia (HP:0003073) | 1.88772343 |
| 65 | Hypoplasia of the fovea (HP:0007750) | 1.88241960 |
| 66 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.88241960 |
| 67 | Retinitis pigmentosa (HP:0000510) | 1.84820346 |
| 68 | Hemiparesis (HP:0001269) | 1.84683700 |
| 69 | Dysdiadochokinesis (HP:0002075) | 1.83811790 |
| 70 | Muscle fiber atrophy (HP:0100295) | 1.82387315 |
| 71 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.82256137 |
| 72 | Recurrent fungal infections (HP:0002841) | 1.82155307 |
| 73 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.81542027 |
| 74 | Abnormality of the renal cortex (HP:0011035) | 1.80957594 |
| 75 | Clumsiness (HP:0002312) | 1.80834868 |
| 76 | Recurrent lower respiratory tract infections (HP:0002783) | 1.80219309 |
| 77 | Abnormal pancreas size (HP:0012094) | 1.77277521 |
| 78 | Increased CSF protein (HP:0002922) | 1.76944163 |
| 79 | Dry hair (HP:0011359) | 1.76325343 |
| 80 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.75692064 |
| 81 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.75681962 |
| 82 | Bronchitis (HP:0012387) | 1.74993740 |
| 83 | Fatigable weakness (HP:0003473) | 1.74529084 |
| 84 | Abnormality of the neuromuscular junction (HP:0003398) | 1.74529084 |
| 85 | Recurrent bacterial skin infections (HP:0005406) | 1.73737509 |
| 86 | Recurrent viral infections (HP:0004429) | 1.73593609 |
| 87 | Ketoacidosis (HP:0001993) | 1.73396861 |
| 88 | Impaired proprioception (HP:0010831) | 1.72761572 |
| 89 | Osteomyelitis (HP:0002754) | 1.72082464 |
| 90 | Generalized aminoaciduria (HP:0002909) | 1.71756406 |
| 91 | Verrucae (HP:0200043) | 1.71382784 |
| 92 | Papilloma (HP:0012740) | 1.71382784 |
| 93 | Focal seizures (HP:0007359) | 1.71170687 |
| 94 | Hypothermia (HP:0002045) | 1.69747184 |
| 95 | Protruding tongue (HP:0010808) | 1.69314437 |
| 96 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.69053033 |
| 97 | Absent/shortened dynein arms (HP:0200106) | 1.68551894 |
| 98 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.68551894 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 1.68424877 |
| 100 | Large for gestational age (HP:0001520) | 1.68251438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.29883845 |
| 2 | CDK19 | 6.23905156 |
| 3 | OXSR1 | 3.70780166 |
| 4 | MAP4K2 | 3.24651508 |
| 5 | PRKD3 | 3.08396082 |
| 6 | MAP4K1 | 2.43461986 |
| 7 | RIPK4 | 2.34708545 |
| 8 | PINK1 | 2.32075158 |
| 9 | WNK3 | 2.23129046 |
| 10 | TNK2 | 2.07717607 |
| 11 | SIK2 | 1.96512298 |
| 12 | MST4 | 1.94887128 |
| 13 | GRK1 | 1.87307410 |
| 14 | DAPK2 | 1.80666253 |
| 15 | MUSK | 1.68444610 |
| 16 | ACVR1B | 1.61610923 |
| 17 | ADRBK2 | 1.49834588 |
| 18 | IKBKE | 1.42107556 |
| 19 | ZAK | 1.33140392 |
| 20 | FGFR3 | 1.30599268 |
| 21 | KIT | 1.28151261 |
| 22 | IKBKB | 1.16859215 |
| 23 | RPS6KB2 | 1.14697826 |
| 24 | TAOK3 | 1.12792320 |
| 25 | BMPR2 | 1.11159535 |
| 26 | MAPK13 | 1.05625808 |
| 27 | CSF1R | 1.05529573 |
| 28 | SYK | 1.05181577 |
| 29 | BMPR1B | 1.04976214 |
| 30 | PRKD2 | 1.04967513 |
| 31 | MAP3K7 | 1.01121254 |
| 32 | PRKCH | 1.00922722 |
| 33 | TAF1 | 1.00884669 |
| 34 | FGFR4 | 1.00796100 |
| 35 | JAK1 | 1.00497452 |
| 36 | BLK | 0.99819995 |
| 37 | MAP3K14 | 0.99659280 |
| 38 | TYK2 | 0.99192758 |
| 39 | IRAK4 | 0.91964578 |
| 40 | SMG1 | 0.91935645 |
| 41 | MARK3 | 0.90780273 |
| 42 | MAPK11 | 0.87800463 |
| 43 | INSRR | 0.80356107 |
| 44 | NEK9 | 0.79015174 |
| 45 | PRKCI | 0.76929641 |
| 46 | STK11 | 0.76851910 |
| 47 | PRKCQ | 0.74934525 |
| 48 | EEF2K | 0.74646288 |
| 49 | VRK1 | 0.74246199 |
| 50 | CHUK | 0.74046828 |
| 51 | TLK1 | 0.73275040 |
| 52 | EPHA3 | 0.72351456 |
| 53 | PDK1 | 0.71458481 |
| 54 | HIPK2 | 0.71368862 |
| 55 | STK4 | 0.70308917 |
| 56 | BTK | 0.68077408 |
| 57 | TBK1 | 0.68058216 |
| 58 | ERN1 | 0.65484891 |
| 59 | MAPKAPK3 | 0.63332602 |
| 60 | STK3 | 0.62569016 |
| 61 | CDK4 | 0.62320282 |
| 62 | LYN | 0.60879486 |
| 63 | DDR2 | 0.60367560 |
| 64 | EIF2AK3 | 0.59636814 |
| 65 | PRKAA2 | 0.58961670 |
| 66 | STK24 | 0.58419455 |
| 67 | MAPKAPK5 | 0.56810143 |
| 68 | YES1 | 0.56727236 |
| 69 | RPS6KA5 | 0.55454297 |
| 70 | PIM1 | 0.53717926 |
| 71 | MAP3K13 | 0.53610233 |
| 72 | MAP2K6 | 0.53168079 |
| 73 | CCNB1 | 0.53058545 |
| 74 | FER | 0.52349040 |
| 75 | FGFR2 | 0.52278199 |
| 76 | MATK | 0.50341255 |
| 77 | TRPM7 | 0.48922166 |
| 78 | PDPK1 | 0.48125645 |
| 79 | PRKCZ | 0.46247181 |
| 80 | CDK8 | 0.46115803 |
| 81 | CAMK1D | 0.45308439 |
| 82 | CDC42BPA | 0.44420723 |
| 83 | PAK3 | 0.43765504 |
| 84 | LIMK1 | 0.43316583 |
| 85 | SIK3 | 0.40041973 |
| 86 | PRKCE | 0.39732359 |
| 87 | PRPF4B | 0.38520345 |
| 88 | DAPK3 | 0.37142299 |
| 89 | TXK | 0.36736718 |
| 90 | UHMK1 | 0.36449037 |
| 91 | DAPK1 | 0.35345910 |
| 92 | MAP3K4 | 0.34785687 |
| 93 | JAK2 | 0.34535212 |
| 94 | PTK2B | 0.34487487 |
| 95 | VRK2 | 0.33919774 |
| 96 | PKN1 | 0.33848724 |
| 97 | ALK | 0.33580569 |
| 98 | STK38L | 0.32371547 |
| 99 | LCK | 0.32049528 |
| 100 | PRKG2 | 0.30244837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.89283297 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.35661525 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.15110953 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.89294421 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.82016176 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.72883608 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.20149899 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.11092092 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.69418003 |
| 10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.11489062 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05480241 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99874787 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.99110015 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.88984368 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.88712719 |
| 16 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.71205963 |
| 17 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.69929477 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51405594 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.41384100 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36092608 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34014677 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.33041290 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.29281516 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.20580158 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.17544906 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.12004125 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11987645 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11397918 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10433765 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01302355 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00658934 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00230049 |
| 33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99859008 |
| 34 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.97948425 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95343003 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91153662 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90848193 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88203963 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 0.84242244 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83290165 |
| 41 | Insulin secretion_Homo sapiens_hsa04911 | 0.83150638 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82685492 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79438116 |
| 44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74922555 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.74872834 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68671901 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67488604 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66877006 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66740319 |
| 50 | Measles_Homo sapiens_hsa05162 | 0.64991727 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64375240 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60767676 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60680751 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 0.59359704 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57430632 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.55261323 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54600945 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54525914 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54176589 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50139298 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48909753 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48716543 |
| 63 | Alcoholism_Homo sapiens_hsa05034 | 0.45855552 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 0.45762564 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43364429 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.42375983 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41686306 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41514488 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40599979 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39744029 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39083087 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35676852 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35181838 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.34377606 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.34174585 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33137884 |
| 77 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.32960571 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30706725 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29999083 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.28604111 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28274845 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27811715 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26460450 |
| 84 | Long-term depression_Homo sapiens_hsa04730 | 0.25975258 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25177634 |
| 86 | RNA polymerase_Homo sapiens_hsa03020 | 0.24901261 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.24249498 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.23501419 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23115627 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20365082 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.19597804 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.19487089 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19259308 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.17267021 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.15396451 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.14269028 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.13522407 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13484382 |
| 99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.13343034 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.13273385 |

